LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

High Blood Sugar Associated with Postoperative Infection

By LabMedica International staff writers
Posted on 04 Oct 2010
Print article
Elevated blood glucose levels can be a predictor of infection after surgical intervention.

Surgical site infection accounts for 14% - 17% of hospital-acquired infections, making it the third most common type of infection acquired at healthcare facilities and the most common among patients having surgery.

In a review of 1,561 patients at Albany Medical College, (Albany, NY, USA), blood glucose values were available for 559 who had vascular surgery, 226 who had colorectal surgery and 776 who had a type of general surgery other than colorectal. Overall, 7.4% of the patients developed surgical site infections, including 14.1% of those who had colorectal surgery, 10.3% who had vascular surgery, and 4.4% of those who had other general surgery.

The most important risk factor for surgical site infection was postoperative hyperglycemia in general and colorectal cancer surgery patients. Those with serum glucose levels higher than 110 mg/dL were associated with increasingly higher rates of postsurgical infection. A subanalysis of colorectal surgery patients found that a postoperative serum glucose level higher than 140 mg/dL was the only significant predictor of surgical site infection. Among vascular surgery patients, operative time and diabetes were the only significant predictors of surgical site infection, which was not associated with postoperative hyperglycemia. The results of the study were published in the September 2010, issue of Archives of Surgery.

The authors noted, "If hyperglycemia is confirmed in future prospective studies with better postoperative glucose data to be an independent risk factor for post surgical infection in general surgery patients, this would give surgeons a modifiable variable to reduce the incidence of postoperative infection. Hyperglycemia may impair the immune system, and insulin may have anti-inflammatory and other anti-infective activities. However, it is possible that the accumulation of other risk factors for surgical site infection causes hyperglycemia rather than vice versa; hence, further study is needed."

Related Links:

Albany Medical College


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centromere B Assay
Centromere B Test
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.